News Articles

Impulse control increased by dopamine replacement in early Parkinson's

8/19/14 - New Penn Medicine research shows that neuropsychiatric symptoms such as depression, anxiety and fatigue are more common in newly diagnosed Parkinson's disease (PD) patients compared to the general...


Patients with Parkinson's Disease often suffer from undiagnosed depression

8/19/14 - Depression is known to be a common symptom of Parkinson's disease, but remains untreated for many patients, according to a new study by Northwestern Medicine investigators in collaboration with the...


High-frequency pulsed electric fields used to disrupt focal blood-brain-barrier

8/14/14 - A team of researchers from the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences have developed a new way of using electricity to open the blood-brain-barrier (BBB).


Discovery of new pathways controlling the serotonergic system

8/8/14 - With the aid of new methods, a research team at Karolinska Institutet have developed a detailed map of the networks of the brain that control the neurotransmitter serotonin.


Transplanted induced neural stem cells become fully integrated in the neuronal network in mice

8/7/14 - Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have grafted neurons reprogrammed from skin cells into the brains of mice for the first time with...


Dyskinesia in Parkinson's disease alleviated by Compound Formula Rehmannia

8/7/14 - Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is...


African plant may have pharmaceutical potential for treating Alzheimer's, Parkinson's or stroke

8/6/14 - Salk scientists find that a plant used for centuries by healers of São Tomé e Príncipe holds lessons for modern medicine.


Two products of the gene DJ-1 can increase the survival of neurons in Parkinson's disease

8/5/14 - Parkinson's disease affects neurons in the Substantia nigra brain region - their mitochondrial activity ceases and the cells die.


First clinical data of therapeutic Parkinson's disease vaccine encourages continued development

8/4/14 - AFFiRiS AG have announced at a press conference in New York results of AFF008, a Phase I clinical trial of PD01A, a vaccine against Parkinson's disease.


Naltrexone may be effective in diminishing impulse control disorders in Parkinson's disease

8/2/14 - Up to 20 percent of Parkinson's disease (PD) patients and their families may confront a common but largely unrecognized challenge: the occurrence of impulse control disorders (ICDs) such as...


Researchers discover new protein structure that could help treat Alzheimer's, related diseases

7/31/14 - There is no cure for Alzheimer's disease and other forms of dementia, but the research community is one step closer to finding treatment.


Neuron loss in Parkinson's model prevented by anti-inflammatory drug

7/29/14 - An experimental anti-inflammatory drug can protect vulnerable neurons and reduce motor deficits in a rat model of Parkinson's disease, researchers at Emory University School of Medicine have shown.


Six new genetic risk factors for Parkinson's identified using gene chip

7/28/14 - A gene chip called NeuroX has helped researchers to identify 24 gene variants - six of which are newly discovered - that increase a person's risk of developing Parkinson's disease.


Treatment identified that prevents tumor metastasis

7/28/14 - Metastasis, the strategy adopted by tumor cells to transform into an aggressive form of cancer, are often associated with a gloomy prognosis.


New mechanism found for neurodegeneration

7/28/14 - A research team led by Jackson Laboratory Professor and Howard Hughes Investigator Susan Ackerman, Ph.D.


Supercomputer used to study a common link between addiction and neurological disease

7/25/14 - Recent published research in the Journal of Clinical Investigation demonstrates how changes in dopamine signaling and dopamine transporter function are linked to neurological and psychiatric...


Potential genetic link found between epilepsy and neurodegenerative disorders

7/25/14 - New epilepsy pathway was previously shown to be involved in Alzheimer's A recent scientific discovery showed that mutations in prickle genes cause epilepsy, which in humans is a brain disorder...


Explaining the molecular basis of age-related memory loss

7/24/14 - From telephone numbers to foreign vocabulary, our brains hold a seemingly endless supply of information. However, as we are getting older, our ability to learn and remember new things declines.


Neurologic response in Parkinson's disease associated with placebo effect

7/22/14 - Parkinson's disease is the second most common neurological disorder, affecting almost 10 million people worldwide.


Human neurodegenerative diseases may be impacted by discovery of a new cellular garbage control pathway

7/22/14 - Several human neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and Huntington's disease but also ageing, are linked to an accumulation of abnormal and aggregated...


Findings in mice fuel the idea that processes of active movement and sensory processing are connected

7/21/14 - A new study by researchers at the University of Oregon published in the journal Neuron describes a brainstem circuit in mice that may help explain how active movement impacts the way the brain...


Dopaminergic neurons from transplanted neural stem cell increased in Parkinson's disease by Zhichan decoction

7/18/14 - There is an increasing interest in Parkinson's disease (PD) treatment by increasing dopamine content and reducing dopaminergic metabolites in the brain.


Potential new approach to brain cancer treatments and a better understanding of Parkinson's disease

7/17/14 - Researchers at the UNC School of Medicine have discovered that the protein PARC/CUL9 helps neurons and brain cancer cells override the biochemical mechanisms that lead to cell death in most other...


Protective effect of α-synuclein knockdown on dopaminergic neurons

7/16/14 - The over-expression of α-synuclein is a major factor in the death of dopaminergic neurons in a methamphetamine-induced model of Parkinson's disease (PD).


Creative energy in Parkinson's sufferers is greater than in healthy individuals

7/16/14 - Prof. Rivka Inzelberg of Tel Aviv University's Sackler Faculty of Medicine and the Sagol Neuroscience Center at Sheba Medical Center, Tel Hashomer, documented the exceptional creativity of...